ArticleCurrent protocols2025

Minimal Component, Protein-Free, and Cost-effective Human Pluripotent Stem Cell Cardiomyocyte Differentiation.

Jessika B Iwanski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.